Related Experiment Videos
Research, introduction, and use: advancing from Norplant.
1Alliance for Microbicide Development, Takoma Park, Maryland 20912, USA. pharriso@aol.com
Contraception
|March 30, 1999
Summary
Norplant, a long-acting contraceptive implant, faced challenges despite being a significant innovation. Lessons learned from its experience can improve future contraceptive development and market entry.
Area of Science:
- Reproductive Health
- Contraceptive Technology
Background:
- Norplant, a long-acting implant contraceptive, represented a major innovation but encountered significant challenges.
- A 1997 Institute of Medicine (IOM) workshop convened to review Norplant's efficacy, safety, and market experience.
Framework:
- The workshop analyzed lessons from Norplant's development and market introduction.
- It explored strategies to foster a more supportive environment for contraceptive research and development.
Implementation:
- The article presents findings from the IOM workshop on implant contraceptives.
- It discusses the practical aspects and difficulties encountered with Norplant's clinical use.
Implications:
- The review highlights the potential for developing next-generation contraceptives.
- It suggests an evolving paradigm is necessary to realize scientific prospects in contraceptive innovation.
Keywords:
AmericasContraceptionContraception ResearchContraceptive AgentsContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive ImplantsContraceptive MethodsDeveloped CountriesEconomic FactorsFamily PlanningLevonorgestrelNorth AmericaNorthern AmericaResearch And DevelopmentTechnologyUnited States